Literature DB >> 21467673

Resveratrol derivatives from Vatica albiramis.

Naohito Abe1, Tetsuro Ito, Masayoshi Oyama, Ryuichi Sawa, Yoshikazu Takahashi, Munekazu Iinuma.   

Abstract

Three new stilbene derivatives, albiraminols A (1) (resveratrol hexamer), B (2) (resveratrol dimer), and vatalbinoside F (3) (mono-glucoside of resveratrol dimer), along with malibatol were isolated from acetone soluble portions of the stem of Vatica albiramis. The structures of the isolates were established on the basis of spectroscopic analyses, including a detailed NMR spectroscopic investigation. The biosynthetic aspects of the isolates are discussed in this paper. Compound 1 is composed of tetrameric resveratrol (vaticanol B (1A)) and dimeric resveratrol (1B) and is the first instance of the resveratrol derivative bearing a 5,6,11,12-tetrahydro-5,11-epoxydibenzo[a,e][8]annulene ring system. Compound 2 possesses a novel 4,5-dihydro-13-oxabenzo[3,4]azuleno[7,8,1-jkl]phenanthrene skeleton in the framework.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467673     DOI: 10.1248/cpb.59.452

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

Review 1.  Chemistry and Biology of Resveratrol-Derived Natural Products.

Authors:  Mitchell H Keylor; Bryan S Matsuura; Corey R J Stephenson
Journal:  Chem Rev       Date:  2015-04-02       Impact factor: 60.622

Review 2.  Update on Phytochemistry and Pharmacology of Naturally Occurring Resveratrol Oligomers.

Authors:  Jie Shen; Qiang Zhou; Pei Li; Zhiqiang Wang; Shuangshuang Liu; Chunnian He; Chunhong Zhang; Peigen Xiao
Journal:  Molecules       Date:  2017-11-24       Impact factor: 4.411

Review 3.  Resveratrol oligomer structure in Dipterocarpaceaeous plants.

Authors:  Tetsuro Ito
Journal:  J Nat Med       Date:  2020-04-30       Impact factor: 2.343

4.  Computation-guided asymmetric total syntheses of resveratrol dimers.

Authors:  Masaya Nakajima; Yusuke Adachi; Tetsuhiro Nemoto
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.